// App-Quantinova.ai

178 : Can the level of CSF Neurofilament Light Chain predict disease progression in Progressive Supranuclear Palsy?

Researchers

Presenter

  • E. Jabbari

Principal Investigators

  • J. Woodside

  • H. Morris

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Progressive supranuclear palsy

Biomarkers

  • Regenerating islet-derived 1 alpha

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved